JAMA Oncology Author Interviews
by JAMA NetworkInterviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
Copyright: American Medical Association, 2020
Episodes
Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer
15m · PublishedInterview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. Hosted by Jack West, MD.
Related Content:
- Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer
Radiosurgery of Spine Metastasis—NRG/RTOG 0631 RCT Final Results
14m · PublishedInterview with Samuel Ryu, MD, author of Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. Hosted by Jack West, MD.
Related Content:
- Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine
Pathologic Complete Response and Clinical Outcomes in Soft Tissue Sarcoma
14m · PublishedInterview with Dian Wang, MD, author of Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. Hosted by Jack West, MD.
Related Content:
- Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
16m · PublishedInterview with Laura A. Bolte, MSc, Geke A. P. Hospers, MD, PhD, and Rinse K. Weersma, MD, PhD, authors of Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma. Hosted by Jack West, MD.
Related Content:
- Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
Adoption of Innovative Therapies Across Oncology Practices
21m · PublishedInterview with Nancy L. Keating, MD, MPH, author of Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy. Hosted by Jack West, MD.
Related Content:
- Adoption of Innovative Therapies Across Oncology Practices—Evidence From Immunotherapy
Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
18m · PublishedInterview with Marco Del Chiaro, MD, PhD, author of Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Hosted by Jack West, MD.
Related Content:
- Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma
18m · PublishedInterview with Linda M. Liau, MD, PhD, author of Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Hosted by Jack West, MD.
Related Content:
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
12m · PublishedInterview with Olivier J. van Not, MD, and Karijn P. M. Suijkerbuijk, MD, PhD, authors of Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma. Hosted by Jack West, MD.
Related Content:
- Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA
16m · PublishedInterview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD.
Related Content:
- Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities
Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA
16m · PublishedInterview with Brent S. Rose, MD, author of Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities. Hosted by Jack West, MD.
Related Content:
- Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities
JAMA Oncology Author Interviews has 114 episodes in total of non- explicit content. Total playtime is 26:41:12. The language of the podcast is English. This podcast has been added on November 27th 2022. It might contain more episodes than the ones shown here. It was last updated on April 23rd, 2024 23:18.
